Food News and Research

RSS

Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS

America's pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

25 Nov 2009

Multiple presentations from clinical and preclinical studies of ISTODAX to be presented

Gloucester Pharmaceuticals today announced multiple presentations from clinical and preclinical studies of ISTODAX® (romidepsin) at the upcoming 51st American Society of Hematology (ASH) Annual Meeting being held in New Orleans, Louisiana, at the Ernest N. Morial Convention Center, December 5 – 8, 2009.

25 Nov 2009

Eisai's NDA for Aricept tablets for treatment of Alzheimer's disease accepted for review

Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's New Drug Application (NDA) for once daily 23 mg Aricept® (donepezil HCl extended release) tablets for the treatment of moderate to severe Alzheimer's disease (AD).

25 Nov 2009

Shanghai Biolaxy receives IND approval for insulin formulation to treat diabetes

Shanghai Biolaxy announced the Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes. This IND approval allows Biolaxy to initiate its first phase I clinical study.

24 Nov 2009

Mayo Clinic Women's HealthSource offers tips to reduce gas

Passing gas -- flatulence -- is normal and happens to everyone. But for some people, excessive gas and pain interfere with normal activities. The November issue of Mayo Clinic Women's HealthSource offers tips to reduce gas.

24 Nov 2009

News outlets examine conditions of refugees in Yemen, malnutrition, cholera risks

Reuters reports that as a new camp capable of hosting 10,000 to 12,000 refugees in Yemen will open in a few weeks, "[m]alnutrition and the risk of a cholera outbreak are threatening lives at Yemen's main camp [Masrak] for people fleeing fighting in the north." According to Thomas Davin, regional UNICEF chief, "Hygiene is terrible, really, really terrible."

24 Nov 2009

RESTAURANT SURVIVAL GUIDE in the EAT THIS, NOT THAT! book series released

The authors of the bestselling EAT THIS, NOT THAT! book series, with more than five million copies in print, today released the ultimate reference book for making the most effective food choices while dining at your favorite restaurants — EAT THIS, NOT THAT! RESTAURANT SURVIVAL GUIDE by David Zinczenko, with Matt Goulding.

24 Nov 2009

Merit Web Health Award for MannatechScience.org

Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced today its educational Web site, MannatechScience.org, has received a merit Web Health Award.

24 Nov 2009

Delcath Systems sponsors "Regional Therapeutic Options for Metastatic Melanoma" symposium

Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, recently sponsored a Satellite Symposium at the World Meeting of Melanoma/Skin Cancer Centers in Berlin, Germany. The session, titled "Regional Therapeutic Options for Metastatic Melanoma," was held on Friday, November 20 and featured updates and observations on a variety of current therapies by clinical leaders in the field.

24 Nov 2009

IFR scientists crystallise protein that may aid gut bacteria bind to the gastrointestinal tract

Scientists have crystallised a protein that may help gut bacteria bind to the gastrointestinal tract. The protein could be used by probiotic producers to identify strains that are likely to be of real benefit to people.

24 Nov 2009

Presence of increased body fat hinders the loss of body weight

The presence of increased body fat, and therefore higher levels of inflammatory substances in the blood, hinders the loss and maintenance of body weight; as shown by a research project of the University of Navarra conducted by Estíbaliz Goyenechea Soto, a scientist at the School of Pharmacy.

24 Nov 2009

Financial results for the third-quarter reported by China Biologic Products

China Biologic Products, Inc. ("China Biologic," or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority- owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. ("Taibang") and Guiyang Dalin Biologic Technologies Co., Ltd. ("Dalin") and its equity investment in Xi'an Huitian Blood Products Co., Ltd. ("Huitian"), today reported financial results for the third quarter ended September 30, 2009.

24 Nov 2009

DSS sets evidence-based guidelines and definitions to treat type 2 diabetes

A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery. The report illustrates the findings of the first international consensus conference -- Diabetes Surgery Summit (DSS) -- where an international group of more than 50 scientific and medical experts agreed on a set of evidence-based guidelines and definitions that are meant to guide the use and study of gastrointestinal surgery to treat type 2 diabetes. The document is considered to be the foundation of diabetes surgery as a medical discipline of its own.

24 Nov 2009

Transcept Pharmaceuticals to discuss the Complete Response Letter for Intermezzo NDA

Transcept Pharmaceuticals, Inc. today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form.

24 Nov 2009

New data indicates early association between anti-inflammatory medication and cardiovascular risk

Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before the product was taken off the market in September 2004, according to a report in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

24 Nov 2009

Scientists determine how insulin resistant drugs alter core biochemical pathways through systems biology approach

Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.

24 Nov 2009

CFSAN releases IFT report

The Food and Drug Administration's Center for Food Safety and Applied Nutrition (CFSAN) today released a report from the Institute of Food Technologists (IFT), which recommends clear objectives be set for all users of a simpler, globally accepted food supply chain that can benefit from existing commercial systems.

24 Nov 2009

Researchers awarded grant to find effective methods for childhood obesity prevention

Childhood obesity is on the rise, and with it comes an increased risk for developing health problems such as type 2 diabetes. The best way to reduce the risk of serious weight-related health issues such as diabetes is to eat healthy and increase physical activity.

24 Nov 2009

Eight nonprofit organizations receive Humana Foundation Economic Response Grants

During the ongoing economic downturn that has touched the entire country, many nonprofit organizations have found their services – such as food pantries, temporary shelters and medical clinics – to be increasingly important to their communities. Complicating

24 Nov 2009

Lysteda tablets to treat menorrhagia approved by the FDA

The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot.

24 Nov 2009

Food News and Research

Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS

Multiple presentations from clinical and preclinical studies of ISTODAX to be presented

Eisai's NDA for Aricept tablets for treatment of Alzheimer's disease accepted for review

Shanghai Biolaxy receives IND approval for insulin formulation to treat diabetes

Mayo Clinic Women's HealthSource offers tips to reduce gas

News outlets examine conditions of refugees in Yemen, malnutrition, cholera risks

RESTAURANT SURVIVAL GUIDE in the EAT THIS, NOT THAT! book series released

Merit Web Health Award for MannatechScience.org

Delcath Systems sponsors "Regional Therapeutic Options for Metastatic Melanoma" symposium

IFR scientists crystallise protein that may aid gut bacteria bind to the gastrointestinal tract

Presence of increased body fat hinders the loss of body weight

Financial results for the third-quarter reported by China Biologic Products

DSS sets evidence-based guidelines and definitions to treat type 2 diabetes

Transcept Pharmaceuticals to discuss the Complete Response Letter for Intermezzo NDA

New data indicates early association between anti-inflammatory medication and cardiovascular risk

Scientists determine how insulin resistant drugs alter core biochemical pathways through systems biology approach

CFSAN releases IFT report

Researchers awarded grant to find effective methods for childhood obesity prevention

Eight nonprofit organizations receive Humana Foundation Economic Response Grants

Lysteda tablets to treat menorrhagia approved by the FDA

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News